AMGN compared with STRO: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

STROSutro Biopharma, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

STROSutro Biopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

STRO1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.6%▼−14.94%×0.72

= impliedAMGN realized, solidSTRO realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedSource: market data

AMGNAmgen Inc

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

STROSutro Biopharma, Inc.

Mkt cap$159.5MRevenue$10MQ2 FY26Revenue$102MFY25

Compare

AMGNAmgen Inc

STROSutro Biopharma, Inc.

Price

$249.0B

Mkt cap

$159.5M

Q3 FY26$10.4B

Revenue

$10MQ2 FY26

FY25$36.8B

Revenue

$102MFY25

AMGNvsSTRO